Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nuohong Huikang Biotechnology

Request full access

GMP-grade cell culture reagents for biomedical research.

ChinaFounded 2023Biotech & Life Sciences

About Nuohong Huikang Biotechnology

Sperikon, also known as Nuohong Huikang Biotechnology, is a high-tech enterprise established in 2020 that focuses on the innovation and production of liquid reagents for cell biology. The company was co-founded by scholars with experience in cell biology and artificial intelligence. The Chairman is Yin Shigang and the General Manager is Wang Zhou. Sperikon aims to build an independent supply chain for the cell biology industry, challenging the market dominance of foreign brands in China's biomedical reagent sector. The company's business model centers on the research, development, production, and sales of reagents for the entire cell biology research process. Its clients include scientific research institutions, biopharmaceutical companies, cell therapy firms, and medical aesthetics organizations. Sperikon provides a "one-stop-shop" for everything from basic research reagents to clinical-grade application solutions. The product portfolio includes serum-free stem cell culture media, serum substitutes, matrix gels, organoid culture kits, and reagents for cell and gene therapy (CGT). These products cater to a wide range of applications, from scientific research to GMP-grade production. A key technological asset is the proprietary SP-EasyM AI intelligent formula research and development platform. This platform utilizes a multi-omics database and neural network algorithms to create an "intelligent mapping model" between culture medium formulas and cell states. This approach precisely predicts the nutritional needs of different cell types, which has been shown to increase new product development efficiency by over 50%. All products are manufactured under strict quality control, adhering to ISO 13485 and cGMP standards. Sperikon operates two main sites: a research and development center in the Deyang Sperikon Industrial Park and a production facility, including a recently announced culture medium powder production workshop in Huai'an. This dual-hub strategy enables the company to manage the entire chain from R&D to large-scale production and supply.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Drug Development, Stem Cells, Biotech and Pharma
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2026 $14M $55M Zero2IPO · Empower Investment ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Nuohong Huikang Biotechnology website traffic

Latest recorded traffic for Nuohong Huikang Biotechnology is 2.4K monthly website visits.

Latest monthly visits2.4K
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nuohong Huikang Biotechnology in its local ecosystem

Live from Dealroom

The Nuohong Huikang Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Zero2IPO
  • Empower Investment
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nuohong Huikang Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nuohong Huikang Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.